Loading the company…
Loading the company…
㈜한국메디칼사푸라이
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Seoul, founded in 1971. Industry: Medical & Precision Devices. Revenue for 2026 was ₩9.3bn. It has 9 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2001-10-30 · latest registration 2002-01-24 · newest first
본 고안은 의료용 카테터의 흡인 커넥터에 관한 것으로, 음압개방에 의한 흡인력을 충분히 조절할 수 있는 동시에 비산방지가 확실하고, 시술자에 대한 오염이나 감염의 우려가 적어 위생적이면서 간단한 구조를 제공한다. 이에 대한 해결수단으로 일단이 가요성 도관(2)에 접속되어 타단이 사용시에 흡인원에 접속되는 유체통로(31)와, 상기 유체통로(31)의 도중에서 분기하여 개구단(33)을 갖는 통기로(32)를 구비한 흡인 커넥터에 있어서, 상기 통기로(32) 내의 적어도 상기 유체통로측의 일부 영역에 저지판(34)이 배치되고, 상기 저지판(34)에 의해 상기 통기로(32)의 단면이 복수의 영역으로 구획되며, 상기 유체통로(31)에서 상기 통기로(32)로 진입하는 유체가 상기 개구단(33)에서 유출하는 것을 상기 저지판(34)으로 저지하도록 구성됨을 특징으로 한다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2025 | 2026 |
|---|---|---|
| Revenue | 9.7 | 9.3 |
| Cost of sales | 8.3 | 7.9 |
| Gross profit (loss) | 1.4 | 1.4 |
| Selling, general and administrative expenses | 1.9 | 2.0 |
| Operating income (loss) | 0.4 | 0.6 |
| Non-operating income | 0.1 | 0.2 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.0 | 0.0 |
| Other | 0.1 | 0.2 |
| Non-operating expenses | 0.5 | 0.4 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.1 | 0.3 |
| Other | 0.4 | 0.1 |
| Income tax expense | 0.4 | — |
| Net income (loss) | 3.6 | 9.8 |
Revenue ₩9.3bn, down 4.0% YoY.
Operating margin 6.3% (prior 4.4%).
Net income ₩9.8bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.